The price, which is confidential & was negotiated for a total of 300 huge number of doses, is somewhat lower than the $19.50 a picture the United States agreed to purchase a very first shipment of 100 million doses of the same vaccine, in series with what Reuters reported in November.
The EU file dated Nov. eighteen was circulated internally after the EU announced its supply offer with Pfizer and the German partner BioNTech of its on Nov. 11.
The EU drug regulator is actually anticipated to determine on Monday on approval for the Pfizer vaccine after the shot was authorised in a number of countries, like Britain as well as the United States.
On Thursday Belgian say secretary on your budget Eva De Bleeker printed on Twitter a table with price tags Belgium would shell out pharmaceutical companies for their COVID 19 vaccines. She retracted the content shortly after posting.
In this dinner table the Pfizer vaccine was suggested as costing Belgium 12 euros ($14.6) per dose, leading many to think this was the total price agreed by way of the EU.
Various other vaccines in the table were additionally shown with rates lower compared to prices disclosed by EU sources.
“There is surely a total price along with a price after delivery,” an EU official involved in talks with vaccine makers told Reuters when directed to clarify the big difference between the EU and Belgian rates.
A spokesman for De Bleeker declined to comment on Monday, citing confidentiality requirements, but pointed to what De Bleeker told the Belgian parliament previous week. In this public hearing, De Beeker stated Belgium’s budgeted costs were still partial.
Under EU advance purchase deals for COVID-19 vaccines, the bloc believes initial payments with business enterprises to secure doses before they are approved. After approvals, EU governments can pay the rest to purchase reserved doses.
The EU hasn’t revealed the initial payment agreed with Pfizer.
Nevertheless, it stated in October which it paid aproximatelly 1 billion euros in downpayments to AstraZeneca, Sanofi and Johnson & Johnson for their shots, with an additional 1.45 billion euros budgeted for upfront payments to Pfizer-BioNTech, Moderna and Curevac.
It’s since agreed source deals with all 6 companies and is negotiating a seventh agreement with Novavax.